Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links

Prostate Cancer and Prostatic Diseases volume 19, pages 7–13 (2016)Cite this article

Subjects

Abstract

Background:

Epidemiological data suggest that lower urinary tract symptoms (LUTSs) may be associated with metabolic syndrome (MetS). Inflammation has been proposed as a candidate mechanism at the crossroad between these two clinical entities. The aim of this review article is to evaluate the role of MetS-induced inflammation in the pathogenesis and progression of LUTS.

Methods:

A systematic review was conducted using the keywords ‘metabolic syndrome and lower urinary tract symptoms’ within the title search engines including PubMed, Web of Science and the Cochrane Library for relevant research work published between 2000 and January 2015. The obtained literature was reviewed by the primary author (QH) and was assessed for eligibility and standard level of evidence.

Results:

Total of 52 articles met the eligibility criteria. On the basis of database search during the past 15 years and our systematic review of prospective and retrospective cohorts, case–control trials, observational studies and animal data identified a possible link between MetS-induced inflammation and LUTS including BPH, bladder outlet obstruction, overactive bladder, urinary incontinence and other possible urinary tract abnormalities.

Conclusions:

There is convincing evidence to suggest that MetS and inflammation could be important contributors to LUTS in men, particularly in the development of BPH. However, the role of MetS-induced inflammation remains unclear in overactive bladder, urinary incontinence and etiology of LUTS progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. King D . The future challenge of obesity. Lancet 2011; 378: 743–744.

    Article  PubMed  Google Scholar 

  2. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.

    Article  CAS  PubMed  Google Scholar 

  3. Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW . Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009; 94: 1853–1878.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Després J-P, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

    Article  PubMed  Google Scholar 

  5. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  PubMed  Google Scholar 

  6. Grundy SM . Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595–2600.

    Article  CAS  PubMed  Google Scholar 

  7. Donnell RF . Benign prostate hyperplasia: a review of the year's progress from bench to clinic. Curr Opin Urol 2011; 21: 22–26.

    Article  PubMed  Google Scholar 

  8. Moul S, McVary KT . Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol 2010; 20: 7–12.

    Article  PubMed  Google Scholar 

  9. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–178.

    Article  PubMed  Google Scholar 

  10. Nickel J . Prostatic inflammation in benign prostatic hyperplasia-the third component? Can J Urol 1994; 1: 1–4.

    CAS  PubMed  Google Scholar 

  11. Welch G, Weinger K, Barry MJ . Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 2002; 59: 245–250.

    Article  PubMed  Google Scholar 

  12. Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 2015; 115: 24–31.

    Article  PubMed  Google Scholar 

  13. De Nunzio C, Cindolo L, Gacci M, Pellegrini F, Carini M, Lombardo R et al. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. Urology 2014; 84: 1181–1187.

    Article  PubMed  Google Scholar 

  14. Bhindi B, Margel D, Trottier G, Hamilton RJ, Kulkarni GS, Hersey KM et al. Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort. Urology 2014; 83: 81–87.

    Article  PubMed  Google Scholar 

  15. Parsons JK, Sarma AV, McVary K, Wei JT . Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 2013; 189: S102–S106.

    PubMed  Google Scholar 

  16. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752–1761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kasturi S, Russell S, McVary KT . Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Prostate Rep 2006; 4: 127–131.

    Article  Google Scholar 

  18. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A . The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007; 51: 199–206.

    Article  PubMed  Google Scholar 

  19. De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder F et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011; 60: 106–117.

    Article  CAS  PubMed  Google Scholar 

  20. Bunn F, Kirby M, Pinkney E, Cardozo L, Chapple C, Chester K et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract 2014; 69: 199–217.

    Article  PubMed  Google Scholar 

  21. Tai H-C, Chung S-D, Ho C-H, Tai T-Y, Yang W-S, Tseng C-H et al. Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 2010; 95: 1143–1150.

    Article  CAS  PubMed  Google Scholar 

  22. Uzun H, Zorba OÜ . Metabolic syndrome in female patients with overactive bladder. Urology 2012; 79: 72–75.

    Article  PubMed  Google Scholar 

  23. Devaraj S, Singh U, Jialal I . Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009; 20: 182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fagerberg B, Behre CJ, Wikstrand J, Hultén LM, Hulthe J . C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis. Scand J Clin Lab Inves 2008; 68: 534–541.

    Article  CAS  Google Scholar 

  25. Greenfield JR, Campbell LV . Relationship between inflammation, insulin resistance and type 2 diabetes:'cause or effect'? Curr Diabetes Rev 2006; 2: 195–211.

    Article  CAS  PubMed  Google Scholar 

  26. Powell K . Obesity: the two faces of fat. Nature 2007; 447: 525–527.

    Article  CAS  PubMed  Google Scholar 

  27. Fibbi B, Penna G, Morelli A, Adorini L, Maggi M . Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl 2010; 33: 475–488.

    Article  CAS  PubMed  Google Scholar 

  28. Kalyani RR, Dobs AS . Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007; 14: 226–234.

    Article  CAS  PubMed  Google Scholar 

  29. Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007; 51: 524–533.

    Article  CAS  PubMed  Google Scholar 

  30. Lotti F, Maggi M . Interleukin 8 and the male genital tract. J reprod Immunol 2013; 100: 54–65.

    Article  CAS  PubMed  Google Scholar 

  31. Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000; 56: 1025–1029.

    Article  CAS  PubMed  Google Scholar 

  32. Liu L, Li Q, Han P, Li X, Zeng H, Zhu Y et al. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia. Urology 2009; 74: 340–344.

    Article  PubMed  Google Scholar 

  33. Lotti F, Corona G, Vignozzi L, Rossi M, Maseroli E, Cipriani S et al. Metabolic syndrome and prostate abnormalities in male subjects of infertile couples. Asian J Androl 2014; 16: 295.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lotti F, Corona G, Vitale P, Maseroli E, Rossi M, Fino M et al. Current smoking is associated with lower seminal vesicles and ejaculate volume, despite higher testosterone levels, in male subjects of infertile couples. Hum Reprod 2015; 30: 590–602.

    Article  CAS  PubMed  Google Scholar 

  35. Penna G, Fibbi B, Amuchastegui S, Cossetti C, Aquilano F, Laverny G et al. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J Immunol 2009; 182: 4056–4064.

    Article  CAS  PubMed  Google Scholar 

  36. Adorini L, Penna G, Fibbi B, Maggi M . Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann NY Acad Sci 2010; 1193: 146–152.

    Article  CAS  PubMed  Google Scholar 

  37. Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E et al. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways. Prostate 2009; 69: 480–493.

    Article  CAS  PubMed  Google Scholar 

  38. Giri D, Ittmann M . Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 2001; 159: 139–147.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Gharaee-Kermani M, Kasina S, Moore BB, Thomas D, Mehra R, Macoska JA . CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. PLoS One 2012; 7: e49278.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Shankar E, Vykhovanets EV, Vykhovanets OV, MacLennan GT, Singh R, Bhaskaran N et al. High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-κB. Prostate 2012; 72: 233–243.

    Article  CAS  PubMed  Google Scholar 

  41. Vykhovanets EV, Shankar E, Vykhovanets OV, Shukla S, Gupta S . High-fat diet increases NF-κB signaling in the prostate of reporter mice. Prostate 2011; 71: 147–156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Maneschi E et al. Tadalafil Effect on Metabolic Syndrome-Associated Bladder Alterations: An Experimental Study in a Rabbit Model. J Sex Med 2014; 11: 1159–1172.

    Article  CAS  PubMed  Google Scholar 

  43. Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M et al. Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol 2014; 382: 107–119.

    Article  CAS  PubMed  Google Scholar 

  44. Robert G, Descazeaud A, Nicolaïew N, Terry S, Sirab N, Vacherot F et al. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate 2009; 69: 1774–1780.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G et al. Evaluation of prostatitis in autopsied prostates—is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 2008; 179: 1736–1740.

    Article  PubMed  PubMed Central  Google Scholar 

  46. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387–2398.

    Article  CAS  PubMed  Google Scholar 

  47. Nickel J, Downey J, Young I, Boag S . Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999; 84: 976–981.

    Article  CAS  PubMed  Google Scholar 

  48. Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M et al. Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men. Eur Urol 2014; 66: 619–622.

    Article  PubMed  Google Scholar 

  49. Kwon YK, Choe MS, Seo KW, Park CH, Chang HS, Kim BH et al. The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment. Korean J Urol 2010; 51: 266–270.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim O et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007; 100: 327–331.

    Article  PubMed  Google Scholar 

  51. Nickel JC, Roehrborn CG, O’Leary MP, Bostwick DG, Somerville MC, Rittmaster RS . The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379–1384.

    Article  PubMed  Google Scholar 

  52. Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I et al. Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology 2013; 81: 1018–1024.

    Article  PubMed  Google Scholar 

  53. Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–336.

    CAS  PubMed  Google Scholar 

  54. Heilbronn LK, Campbell LV . Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008; 14: 1225–1230.

    Article  CAS  PubMed  Google Scholar 

  55. Biernacka A, Dobaczewski M, Frangogiannis NG . TGF-β signaling in fibrosis. Growth Factors 2011; 29: 196–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Liu Y . Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684–696.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Rodriguez-Nieves JA, Macoska JA . Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol 2013; 10: 546–550.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Kuo H-C, Liu H-T, Shie J-H . Potential urine and serum biomarkers for patients with overactive bladder and interstitial cystitis/bladder pain syndrome. Tzu Chi Med J 2013; 25: 13–18.

    Article  Google Scholar 

  59. Hsiao S-M, Lin H-H, Kuo H-C . The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 2012; 23: 935–940.

    Article  PubMed  Google Scholar 

  60. Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 2010; 42: 629–635.

    Article  PubMed  Google Scholar 

  61. Chung SD, Liu HT, Lin H, Kuo HC . Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 2011; 30: 417–420.

    Article  CAS  PubMed  Google Scholar 

  62. Lenis AT, Kuang M, Woo LL, Hijaz A, Penn MS, Butler RS et al. Impact of parturition on chemokine homing factor expression in the vaginal distention model of stress urinary incontinence. J Urol 2013; 189: 1588–1594.

    Article  CAS  PubMed  Google Scholar 

  63. Chen H-Y, Lin Y-N, Chen Y-H, Chen W-C . Stress urinary incontinence following vaginal trauma involves remodeling of urethral connective tissue in female mice. Eur J Obstet Gynecol Reprod Biol 2012; 163: 224–229.

    Article  PubMed  Google Scholar 

  64. Chen H-Y, Chen C-J, Lin Y-N, Chen Y-H, Chen W-C, Chen C-M . Proteomic analysis related to stress urinary incontinence following vaginal trauma in female mice. Eur J Obstet Gynecol Reprod Biol 2013; 171: 171–179.

    Article  CAS  PubMed  Google Scholar 

  65. Juan YS, Chuang SM, Lee YL, Long CY, Wu TH, Chang WC et al. Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model. BJU Int 2012; 110: E236–E244.

    Article  CAS  PubMed  Google Scholar 

  66. Wang L-w, Han X-m, Chen C-h, Ma Y, Hai B . Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int Urol Nephrol 2014; 46: 341–347.

    Article  CAS  PubMed  Google Scholar 

  67. Agilli M, Aydin FN, Kurt YG, Cayci T . A potential biomarker for objective diagnosis of overactive bladder: urinary nerve growth factor. Int Urol Nephrol 2014; 47: 317–318.

    Article  PubMed  Google Scholar 

  68. Bhide AA, Cartwright R, Khullar V, Digesu GA . Biomarkers in overactive bladder. Int Urogynecol J 2013; 24: 1065–1072.

    Article  PubMed  Google Scholar 

  69. Dallosso H, McGrother C, Matthews RJ, Donaldson M . The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003; 92: 69–77.

    Article  CAS  PubMed  Google Scholar 

  70. Link CL, Steers WD, Kusek JW, McKinlay JB . The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey. J Urol 2011; 185: 955–963.

    Article  PubMed  PubMed Central  Google Scholar 

  71. He Q, Wang H, Yue Z, Yang L, Tian J, Liu G et al. Waist circumference and risk of lower urinary tract symptoms: a meta-analysis. Aging Male 2014; 17: 223–229.

    Article  PubMed  Google Scholar 

  72. Tsai Y-C, Liu C-H . Urinary incontinence among Taiwanese women: an outpatient study of prevalence, comorbidity, risk factors, and quality of life. Int Urol Nephrol 2009; 41: 795–803.

    Article  PubMed  Google Scholar 

  73. Uzun H, Yilmaz A, Kemik A, Zorba OU, Kalkan M . Association of insulin resistance with overactive bladder in female patients. Int Neurourol J 2012; 16: 181–186.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Sutcliffe S, Giovannucci E, De Marzo AM, Willett WC, Platz EA . Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms. Am J Epidemiol 2005; 162: 898–906.

    Article  PubMed  Google Scholar 

  75. Krieger JN, Lee SWH, Jeon J, Cheah PY, Liong ML, Riley DE . Epidemiology of prostatitis. Int J Antimicrob Agents 2008; 31: 85–90.

    Article  Google Scholar 

  76. Colodner R, Eliasberg T, Chazan B, Raz R . Clinical significance of bacteriuria with low colony counts of Enterococcus species. Eur J Clin Microbiol Infect Dis 2006; 25: 238–241.

    Article  CAS  PubMed  Google Scholar 

  77. Lee S, Yang G, Bushman W . Prostatic inflammation induces urinary frequency in adult mice. PLoS One 2015; 10: e0116827.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Steigedal M, Marstad A, Haug M, Damås JK, Strong RK, Roberts PL et al. Lipocalin 2 Imparts Selective Pressure on Bacterial Growth in the Bladder and Is Elevated in Women with Urinary Tract Infection. J Immunol 2014; 193: 6081–6089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Eynard AR, Navarro A . Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition 2013; 29: 930–938.

    Article  CAS  PubMed  Google Scholar 

  80. Jou Y-C, Tsai Y-S, Fang C-Y, Chen S-Y, Chen F-H, Huang C-H et al. Mass Spectrometric Study of Stone Matrix Proteins of Human Bladder Stones. Urology 2013; 82: 295–300.

    Article  PubMed  Google Scholar 

  81. Keddis MT, Rule AD . Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens 2013; 22: 390.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We apologize to those investigators whose original work could not be cited owing to the space limitation. The original work cited in this review was supported by grants from United States Public Health Services P20DK090871 and 201306180078 from China Scholarship Council.

Author information

Authors and Affiliations

  1. Department of Urology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA

    Q He & S Gupta

  2. Department of Urology, Key Laboratory of Disease of Urological Systems, Gansu Nephro-Urological Clinical Center, Second Hospital of Lanzhou University, Lanzhou, Gansu, China

    Q He & Z Wang

  3. Department of Surgery, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA

    G Liu & F Daneshgari

  4. Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA

    G T MacLennan

Authors
  1. Q He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Daneshgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G T MacLennan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Gupta.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, Q., Wang, Z., Liu, G. et al. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis 19, 7–13 (2016). https://doi.org/10.1038/pcan.2015.43

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2015.43

This article is cited by

Search

Advanced search

Quick links